Type 2 diabetes (T2DM), the most common affecting > 90% of people diagnosed with DM, results from an inability of pancreatic β-cells to produce sufficient insulin to stimulate glucose utilization by peripheral metabolically active organs to maintain glucose homoeostasis (2). This evidence concerns the gene INS and type 2 diabetes mellitus.